Alfredo Nicosia
Cited by
Cited by
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
E Scarselli, H Ansuini, R Cerino, RM Roccasecca, S Acali, G Filocamo, ...
The EMBO journal, 2002
Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor
B Bartosch, A Vitelli, C Granier, C Goujon, J Dubuisson, S Pascale, ...
Journal of Biological Chemistry 278 (43), 41624-41630, 2003
The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain
M Frain, G Swart, P Monaci, A Nicosia, S Stämpfli, R Frank, R Cortese
Cell 59 (1), 145-157, 1989
Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man
E Barnes, A Folgori, S Capone, L Swadling, S Aston, A Kurioka, J Meyer, ...
Science translational medicine 4 (115), 115ra1-115ra1, 2012
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication.
A Nicosia, M Perugini, C Franzini, MC Casagli, MG Borri, G Antoni, ...
Proceedings of the National Academy of Sciences 83 (13), 4631-4635, 1986
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
DA Stanley, AN Honko, C Asiedu, JC Trefry, AW Lau-Kilby, JC Johnson, ...
Nature medicine 20 (10), 1126-1129, 2014
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
A Folgori, S Capone, L Ruggeri, A Meola, E Sporeno, BB Ercole, ...
Nature medicine 12 (2), 190-197, 2006
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
L Swadling, S Capone, RD Antrobus, A Brown, R Richardson, EW Newell, ...
Science translational medicine 6 (261), 261ra153-261ra153, 2014
A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera.
A Folgori, R Tafi, A Meola, F Felici, G Galfre, R Cortese, P Monaci, ...
The EMBO journal 13 (9), 2236-2243, 1994
Chimpanzee adenovirus vector Ebola vaccine
JE Ledgerwood, AD DeZure, DA Stanley, EE Coates, L Novik, ME Enama, ...
New England Journal of Medicine 376 (10), 928-938, 2017
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
KJ Ewer, GA O’Hara, CJA Duncan, KA Collins, SH Sheehy, ...
Nature communications 4 (1), 2836, 2013
Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species
S Colloca, E Barnes, A Folgori, V Ammendola, S Capone, A Cirillo, ...
Science translational medicine 4 (115), 115ra2-115ra2, 2012
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2
A Higginbottom, ER Quinn, CC Kuo, M Flint, LH Wilson, E Bianchi, ...
Journal of virology 74 (8), 3642-3649, 2000
A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA
K Ewer, T Rampling, N Venkatraman, G Bowyer, D Wright, T Lambe, ...
New England Journal of Medicine 374 (17), 1635-1646, 2016
A model for the hepatitis C virus envelope glycoprotein E2
AT Yagnik, A Lahm, A Meola, RM Roccasecca, BB Ercole, A Nicosia, ...
Proteins: Structure, Function, and Bioinformatics 40 (3), 355-366, 2000
Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2
RM Roccasecca, H Ansuini, A Vitelli, A Meola, E Scarselli, S Acali, ...
Journal of virology 77 (3), 1856-1867, 2003
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector
GA O’Hara, CJA Duncan, KJ Ewer, KA Collins, SC Elias, FD Halstead, ...
Journal of Infectious Diseases 205 (5), 772-781, 2012
Two different liver‐specific factors stimulate in vitro transcription from the human alpha 1‐antitrypsin promoter.
P Monaci, A Nicosia, R Cortese
The EMBO journal 7 (7), 2075-2087, 1988
Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+ T …
A Reyes-Sandoval, T Berthoud, N Alder, L Siani, SC Gilbert, A Nicosia, ...
Infection and immunity 78 (1), 145-153, 2010
ChAd63-MVA–vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans
SH Sheehy, CJA Duncan, SC Elias, P Choudhary, S Biswas, FD Halstead, ...
Molecular Therapy 20 (12), 2355-2368, 2012
The system can't perform the operation now. Try again later.
Articles 1–20